Articles related to Oncology, Radiation

The targeted chemotherapy pill AOH1996, developed by the City of Hope, has shown promising results in preclinical research by targeting PCNA, a protein once thought to be too challenging for targeted therapy. Explore the potential of this novel approach as it advances to phase 1 clinical trials.

The recent study on bevacizumab’s effect on ovarian cancer progression provides valuable insights into its initial benefits and subsequent risks.

The IDEA study’s findings have led to a notable change in the treatment of stage III colon cancer, with a shift towards a 3-month duration using CAPOX. Explore the detailed analysis and its implications for your practice.

The rapid exhaustion of T cells upon encountering a tumor, as revealed in a recent study, challenges existing theories and may have profound implications for cancer immunotherapies. Explore the findings to understand how this discovery could influence the future of personalized treatment.

A recent study on glioma brain tumors reveals the significant role of epigenetic changes in tumor formation. This discovery offers promising avenues for targeted therapies, potentially transforming the approach to treating this devastating disease.

This phase 2 trial demonstrates the potential of perioperative nivolumab combined with chemotherapy in achieving higher pathological complete response and survival rates in stage III NSCLC. Explore the detailed findings to understand how this approach may influence future treatment paradigms.